Cancer Research Annual Meeting 2010  2010 Workshops
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1884-1886, September 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaudhry, A. P.
Right arrow Articles by Schmutz, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaudhry, A. P.
Right arrow Articles by Schmutz, J. A., Jr.

Effects of Prednisolone and Thalidomide on Induced Submandibular Gland Tumors in Hamsters1

Anand P. Chaudhry2 and John A. Schmutz, Jr.2

Department of Pathology, University of Pittsburgh School of Dentistry, Pittsburgh, Pennsylvania

No significant difference in the incidence of induced fibrosarcomas in hamster submandibular glands was noted when the animals were given a single intraglandular injection of 100, 200, 500, and 1000 µg of prednisolone concurrently with administration of 0.05 ml of 0.5% 7:12-dimethylbenz({alpha})anthracene (DMBA) in liquid petrolatum. There was, however, an inhibitory trend when, in addition to the initial intraglandular injection of 500 µg of prednisolone, the same amount was injected i.p. every week throughout the experiment. There was a higher but insignificant incidence of metastasis in prednisolone-treated hamsters as compared to the controls.

Thalidomide failed to show any influence on induced tumors when given to hamsters in a similar procedure using 3 dosage levels, a single 5- or 10-mg dose, and a 5-mg initial injection plus 5 mg/week.

1 This investigation was supported in part by USPHS Grant 2 RO 1 HD00169-03, and in part by Health Research and Services Foundation Grant F-3.

2 Present address: Department of Pathology, Capen Hall, State University of New York at Buffalo, Buffalo, New York.

Received 2/24/66.


This article has been cited by other articles:


Home page
Toxicol PatholHome page
J. E. Dillberger, N. S. Cronin, and G. J. Carr
Prednisone is Not a Mouse Carcinogen
Toxicol Pathol, January 1, 1992; 20(1): 18 - 26.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.